| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.966 | 0.002 | 0.978 | Aldehyde oxidase inhibitor | 0.868 0.004 CID_45039956 0.813 0.004 CID_19080 0.978 0.001 CID_416254 | CID_416254 | |
| 0.548 | 0.01 | 0.585 | Amyloid beta aggregation inhibitor | 0.512 0.013 CID_45039956 0.432 0.021 CID_19080 0.585 0.008 CID_416254 | CID_416254 | |
| 0.545 | 0.012 | 0.555 | Antiamyloidogenic | 0.497 0.016 CID_45039956 0.425 0.025 CID_19080 0.555 0.011 CID_416254 | CID_416254 | |
| 0.504 | 0.005 | 0.56 | Butyrylcholinesterase inhibitor | 0.456 0.005 CID_45039956 0.56 0.004 CID_19080 0.478 0.005 CID_416254 | CID_19080 | |
| 0.463 | 0.005 | 0.663 | Acetylcholinesterase inhibitor | 0.4 0.007 CID_45039956 0.663 0.004 CID_19080 0.43 0.005 CID_416254 | CID_19080 | |
| 0.443 | 0.008 | 0.649 | Cholinergic | 0.364 0.012 CID_45039956 0.649 0.004 CID_19080 0.403 0.01 CID_416254 | CID_19080 | |
| 0.404 | 0.002 | 0.495 | Histamine N-methyltransferase inhibitor | 0.217 0.005 CID_45039956 0.22 0.004 CID_19080 0.495 0.002 CID_416254 | CID_416254 | |
| 0.467 | 0.074 | 0.473 | Caspase 9 stimulant | 0.29 0.205 CID_45039956 0.473 0.071 CID_19080 0.438 0.089 CID_416254 | CID_19080 | |
| 0.378 | 0.05 | 0.686 | 5 Hydroxytryptamine release stimulant | 0.686 0.008 CID_45039956 0.461 0.034 CID_19080 0.419 0.042 CID_416254 | CID_45039956 | |
| 0.367 | 0.048 | 0.412 | Spasmolytic | 0.236 0.097 CID_45039956 0.412 0.038 CID_416254 | CID_416254 | |
| 0.387 | 0.087 | 0.447 | 5 Hydroxytryptamine release inhibitor | 0.284 0.183 CID_45039956 0.447 0.053 CID_19080 0.421 0.066 CID_416254 | CID_19080 | |
| 0.306 | 0.006 | 0.443 | NADH dehydrogenase inhibitor | 0.147 0.018 CID_45039956 0.187 0.012 CID_19080 0.443 0.004 CID_416254 | CID_416254 | |
| 0.307 | 0.014 | 0.307 | Nav1.2 sodium channel blocker | 0.183 0.041 CID_45039956 0.105 0.104 CID_19080 0.263 0.02 CID_416254 | ||
| 0.318 | 0.036 | 0.318 | Sigma receptor agonist | 0.141 0.092 CID_19080 0.294 0.04 CID_416254 | ||
| 0.308 | 0.048 | 0.347 | Superoxide dismutase inhibitor | 0.292 0.053 CID_45039956 0.336 0.04 CID_19080 0.347 0.037 CID_416254 | CID_416254 | |
| 0.303 | 0.043 | 0.362 | 5 Hydroxytryptamine uptake stimulant | 0.362 0.022 CID_45039956 0.31 0.04 CID_19080 0.331 0.032 CID_416254 | CID_45039956 | |
| 0.264 | 0.011 | 0.279 | ATPase inhibitor | 0.209 0.03 CID_45039956 0.216 0.026 CID_19080 0.279 0.008 CID_416254 | CID_416254 | |
| 0.288 | 0.044 | 0.3 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.217 0.079 CID_45039956 0.182 0.106 CID_19080 0.3 0.039 CID_416254 | CID_416254 | |
| 0.309 | 0.08 | 0.309 | Vasodilator, coronary | 0.293 0.093 CID_45039956 0.279 0.106 CID_416254 | ||
| 0.347 | 0.14 | 0.369 | Apoptosis agonist | 0.336 0.147 CID_45039956 0.296 0.175 CID_19080 0.369 0.129 CID_416254 | CID_416254 | |
| 0.252 | 0.046 | 0.29 | DNA methyltransferase I inhibitor | 0.173 0.084 CID_45039956 0.29 0.03 CID_19080 0.256 0.044 CID_416254 | CID_19080 | |
| 0.251 | 0.047 | 0.282 | DNA methylase inhibitor | 0.186 0.089 CID_45039956 0.282 0.033 CID_19080 0.252 0.047 CID_416254 | CID_19080 | |
| 0.222 | 0.019 | 0.222 | Nav1.3 sodium channel blocker | 0.21 0.021 CID_45039956 0.179 0.032 CID_416254 | ||
| 0.218 | 0.014 | 0.218 | Nav1.6 sodium channel blocker | 0.156 0.048 CID_45039956 0.125 0.088 CID_19080 0.182 0.027 CID_416254 | ||
| 0.212 | 0.013 | 0.244 | Telomerase inhibitor | 0.161 0.019 CID_45039956 0.175 0.017 CID_19080 0.244 0.01 CID_416254 | CID_416254 | |
| 0.216 | 0.022 | 0.239 | DNA intercalator | 0.185 0.03 CID_45039956 0.239 0.018 CID_19080 0.228 0.019 CID_416254 | CID_19080 | |
| 0.225 | 0.034 | 0.225 | MAO inhibitor | 0.165 0.054 CID_45039956 0.163 0.054 CID_19080 0.225 0.034 CID_416254 | ||
| 0.244 | 0.061 | 0.273 | Psychostimulant | 0.273 0.051 CID_45039956 0.141 0.124 CID_19080 0.259 0.055 CID_416254 | CID_45039956 | |
| 0.274 | 0.094 | 0.315 | Caspase 3 stimulant | 0.261 0.103 CID_45039956 0.315 0.072 CID_19080 0.264 0.101 CID_416254 | CID_19080 | |
| 0.201 | 0.023 | 0.201 | Alpha 2b adrenoreceptor antagonist | 0.181 0.028 CID_45039956 0.106 0.069 CID_19080 0.148 0.039 CID_416254 | ||
| 0.228 | 0.064 | 0.513 | ErbB-1 antagonist | 0.195 0.095 CID_45039956 0.513 0.008 CID_19080 0.22 0.071 CID_416254 | CID_19080 | |
| 0.234 | 0.072 | 0.265 | Neuropeptide Y2 antagonist | 0.197 0.126 CID_45039956 0.265 0.043 CID_416254 | CID_416254 | |
| 0.246 | 0.085 | 0.246 | Cardiotonic | 0.226 0.099 CID_416254 | ||
| 0.238 | 0.088 | 0.292 | DNA damaging | 0.235 0.09 CID_45039956 0.292 0.06 CID_19080 0.244 0.084 CID_416254 | CID_19080 | |
| 0.253 | 0.103 | 0.26 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.199 0.158 CID_45039956 0.195 0.163 CID_19080 0.26 0.097 CID_416254 | CID_416254 | |
| 0.175 | 0.03 | 0.175 | MAO B inhibitor | 0.121 0.05 CID_45039956 0.092 0.064 CID_19080 0.175 0.03 CID_416254 | ||
| 0.181 | 0.037 | 0.181 | Anesthetic local | 0.113 0.072 CID_45039956 0.163 0.043 CID_416254 | ||
| 0.274 | 0.135 | 0.622 | GABA C receptor rho-3 antagonist | 0.286 0.125 CID_45039956 0.622 0.005 CID_19080 0.457 0.039 CID_416254 | CID_19080 | |
| 0.272 | 0.14 | 0.43 | Histamine release inhibitor | 0.43 0.06 CID_19080 0.39 0.081 CID_416254 | CID_19080 | |
| 0.156 | 0.031 | 0.169 | Nav1.1 sodium channel blocker | 0.093 0.075 CID_45039956 0.169 0.027 CID_416254 | CID_416254 | |
| 0.226 | 0.101 | 0.276 | 5 Hydroxytryptamine 1E antagonist | 0.276 0.048 CID_19080 0.205 0.125 CID_416254 | CID_19080 | |
| 0.148 | 0.033 | 0.148 | Alpha 2c adrenoreceptor antagonist | 0.136 0.04 CID_45039956 0.11 0.058 CID_19080 0.114 0.054 CID_416254 | ||
| 0.16 | 0.051 | 0.203 | Neuropeptide Y1 antagonist | 0.203 0.018 CID_45039956 0.162 0.049 CID_19080 0.159 0.053 CID_416254 | CID_45039956 | |
| 0.138 | 0.036 | 0.141 | Falcipain inhibitor | 0.13 0.04 CID_45039956 0.09 0.063 CID_19080 0.141 0.035 CID_416254 | CID_416254 | |
| 0.134 | 0.036 | 0.136 | Falcipain 2 inhibitor | 0.124 0.04 CID_45039956 0.089 0.06 CID_19080 0.136 0.035 CID_416254 | CID_416254 | |
| 0.141 | 0.045 | 0.181 | Topoisomerase I inhibitor | 0.126 0.052 CID_45039956 0.147 0.042 CID_19080 0.181 0.031 CID_416254 | CID_416254 | |
| 0.195 | 0.102 | 0.271 | Free radical scavenger | 0.205 0.094 CID_45039956 0.271 0.06 CID_416254 | CID_416254 | |
| 0.137 | 0.045 | 0.149 | MAO A inhibitor | 0.114 0.056 CID_45039956 0.13 0.048 CID_19080 0.149 0.041 CID_416254 | CID_416254 | |
| 0.095 | 0.005 | 0.095 | CC chemokine 4 receptor antagonist | 0.065 0.013 CID_45039956 0.043 0.039 CID_19080 0.062 0.014 CID_416254 | ||
| 0.165 | 0.075 | 0.188 | Death-associated protein kinase 2 inhibitor | 0.159 0.087 CID_19080 0.188 0.045 CID_416254 | CID_416254 | |
| 0.141 | 0.056 | 0.165 | Cyclooxygenase 3 inhibitor | 0.165 0.037 CID_19080 0.14 0.057 CID_416254 | CID_19080 | |
| 0.095 | 0.01 | 0.145 | Botulinum neurotoxin type A inhibitor | 0.105 0.008 CID_45039956 0.07 0.025 CID_19080 0.145 0.005 CID_416254 | CID_416254 | |
| 0.1 | 0.015 | 0.1 | Potassium channel (ATP-sensitive) blocker | 0.07 0.041 CID_45039956 0.092 0.02 CID_19080 0.081 0.027 CID_416254 | ||
| 0.128 | 0.047 | 0.22 | Chelator | 0.115 0.059 CID_45039956 0.22 0.021 CID_416254 | CID_416254 | |
| 0.145 | 0.066 | 0.191 | Toll-Like receptor 9 antagonist | 0.191 0.04 CID_19080 | CID_19080 | |
| 0.135 | 0.057 | 0.181 | Topoisomerase II inhibitor | 0.149 0.05 CID_45039956 0.169 0.042 CID_19080 0.181 0.038 CID_416254 | CID_416254 | |
| 0.119 | 0.042 | 0.119 | Sphingomyelinase inhibitor | 0.088 0.075 CID_45039956 0.106 0.054 CID_19080 | ||
| 0.168 | 0.092 | 0.168 | P-glycoprotein inhibitor | 0.156 0.108 CID_45039956 0.147 0.121 CID_416254 | ||
| 0.08 | 0.005 | 0.08 | Benzodiazepine antagonist | 0.058 0.015 CID_45039956 0.068 0.008 CID_19080 0.051 0.025 CID_416254 | ||
| 0.087 | 0.012 | 0.087 | Corticotropin releasing factor 2 receptor antagonist | 0.081 0.016 CID_45039956 0.064 0.038 CID_19080 0.073 0.025 CID_416254 | ||
| 0.146 | 0.079 | 0.335 | GABA C receptor rho-2 antagonist | 0.186 0.038 CID_45039956 0.335 0.004 CID_19080 0.162 0.059 CID_416254 | CID_19080 | |
| 0.233 | 0.168 | 0.433 | Calcium channel activator | 0.433 0.015 CID_19080 | CID_19080 | |
| 0.101 | 0.04 | 0.259 | Glutamate release inhibitor | 0.118 0.023 CID_45039956 0.259 0.004 CID_19080 0.084 0.079 CID_416254 | CID_19080 | |
| 0.065 | 0.01 | 0.065 | Plasmepsin II inhibitor | 0.049 0.019 CID_45039956 0.045 0.022 CID_416254 | ||
| 0.167 | 0.113 | 0.23 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.23 0.052 CID_19080 0.195 0.076 CID_416254 | CID_19080 | |
| 0.151 | 0.099 | 0.194 | Neurotensin receptor agonist | 0.194 0.038 CID_45039956 0.173 0.058 CID_19080 0.174 0.056 CID_416254 | CID_45039956 | |
| 0.112 | 0.061 | 0.168 | Acetylcholine release stimulant | 0.168 0.009 CID_19080 | CID_19080 | |
| 0.07 | 0.02 | 0.074 | Bcl-xL inhibitor | 0.062 0.033 CID_45039956 0.074 0.016 CID_416254 | CID_416254 | |
| 0.106 | 0.057 | 0.117 | Factor V inhibitor | 0.117 0.042 CID_45039956 0.106 0.057 CID_416254 | CID_45039956 | |
| 0.167 | 0.118 | 0.167 | Potassium channel blocker | |||
| 0.093 | 0.044 | 0.104 | Myeloperoxidase inhibitor | 0.1 0.035 CID_45039956 0.103 0.031 CID_19080 0.104 0.03 CID_416254 | CID_416254 | |
| 0.125 | 0.077 | 0.128 | Toll-Like receptor antagonist | 0.128 0.074 CID_19080 0.118 0.088 CID_416254 | CID_19080 | |
| 0.072 | 0.025 | 0.096 | Potassium channel (Ca-activated) blocker | 0.055 0.054 CID_45039956 0.096 0.011 CID_19080 | CID_19080 | |
| 0.09 | 0.046 | 0.175 | Topoisomerase II alpha inhibitor | 0.113 0.032 CID_45039956 0.175 0.019 CID_19080 0.119 0.03 CID_416254 | CID_19080 | |
| 0.101 | 0.062 | 0.115 | Folate antagonist | 0.115 0.043 CID_45039956 0.1 0.064 CID_19080 0.099 0.066 CID_416254 | CID_45039956 | |
| 0.137 | 0.098 | 0.175 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.175 0.075 CID_19080 0.152 0.087 CID_416254 | CID_19080 | |
| 0.147 | 0.113 | 0.166 | Catenin beta inhibitor | 0.165 0.074 CID_19080 0.166 0.073 CID_416254 | CID_416254 | |
| 0.096 | 0.063 | 0.112 | Interleukin 1 beta converting enzyme inhibitor | 0.105 0.051 CID_45039956 0.112 0.043 CID_416254 | CID_416254 | |
| 0.054 | 0.021 | 0.126 | Potassium channel small-conductance Ca-activated blocker | 0.126 0.005 CID_19080 | CID_19080 | |
| 0.043 | 0.011 | 0.043 | Benzodiazepine receptor peripheral-type antagonist | 0.033 0.028 CID_19080 0.037 0.018 CID_416254 | ||
| 0.075 | 0.046 | 0.075 | Calcium channel L-type blocker | |||
| 0.105 | 0.077 | 0.105 | Calcium channel (voltage-sensitive) blocker | |||
| 0.126 | 0.1 | 0.163 | Acetylcholine M1 receptor antagonist | 0.163 0.064 CID_416254 | CID_416254 | |
| 0.079 | 0.054 | 0.091 | Interferon agonist | 0.091 0.038 CID_416254 | CID_416254 | |
| 0.061 | 0.038 | 0.095 | Heat shock protein 90 beta antagonist | 0.069 0.029 CID_45039956 0.066 0.032 CID_19080 0.095 0.013 CID_416254 | CID_416254 | |
| 0.082 | 0.061 | 0.105 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.076 0.07 CID_45039956 0.105 0.034 CID_19080 0.089 0.051 CID_416254 | CID_19080 | |
| 0.112 | 0.097 | 0.112 | Calcium channel blocker | |||
| 0.08 | 0.065 | 0.115 | Antineoplastic alkaloid | 0.115 0.04 CID_19080 0.1 0.047 CID_416254 | CID_19080 | |
| 0.044 | 0.029 | 0.083 | Dihydrofolate reductase inhibitor | 0.044 0.029 CID_45039956 0.083 0.005 CID_19080 | CID_19080 | |
| 0.024 | 0.014 | 0.024 | Corticotropin releasing factor 1 receptor antagonist | 0.021 0.018 CID_45039956 | ||
| 0.137 | 0.127 | 0.157 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.157 0.106 CID_416254 | CID_416254 | |
| 0.032 | 0.022 | 0.032 | GHS receptor antagonist | |||
| 0.058 | 0.048 | 0.078 | 5 Hydroxytryptamine 5A antagonist | 0.078 0.025 CID_19080 | CID_19080 | |
| 0.081 | 0.072 | 0.145 | Granulocyte macrophage colony stimulating factor agonist | 0.145 0.006 CID_19080 | CID_19080 | |
| 0.181 | 0.173 | 0.264 | Tyrosine 3 hydroxylase inhibitor | 0.194 0.147 CID_19080 0.264 0.056 CID_416254 | CID_416254 | |
| 0.098 | 0.09 | 0.12 | Alkylator | 0.096 0.093 CID_45039956 0.12 0.068 CID_416254 | CID_416254 | |
| 0.165 | 0.157 | 0.219 | Peptidyltransferase inhibitor | 0.219 0.078 CID_45039956 0.219 0.078 CID_416254 | CID_416254 | |
| 0.033 | 0.026 | 0.045 | Phosphoglycerate kinase inhibitor | 0.045 0.016 CID_19080 0.039 0.02 CID_416254 | CID_19080 | |
| 0.054 | 0.048 | 0.074 | 5 Hydroxytryptamine 5 antagonist | 0.074 0.023 CID_19080 | CID_19080 | |
| 0.109 | 0.105 | 0.165 | Lipid peroxidase inhibitor | 0.165 0.059 CID_416254 | CID_416254 | |
| 0.039 | 0.036 | 0.039 | Cathepsin F inhibitor | 0.039 0.036 CID_416254 | ||
| 0.12 | 0.117 | 0.131 | Thiol protease inhibitor | 0.131 0.094 CID_416254 | CID_416254 | |
| 0.075 | 0.072 | 0.226 | NMDA receptor antagonist | 0.095 0.05 CID_45039956 0.154 0.023 CID_19080 0.226 0.011 CID_416254 | CID_416254 | |
| 0.152 | 0.15 | 0.219 | Cyclic AMP phosphodiesterase inhibitor | 0.219 0.081 CID_19080 0.152 0.15 CID_416254 | CID_19080 | |
| 0.108 | 0.107 | 0.164 | Histone deacetylase SIRT1 inhibitor | 0.164 0.051 CID_45039956 0.142 0.069 CID_416254 | CID_45039956 | |
| 0.059 | 0.058 | 0.071 | Beta 3 adrenoreceptor antagonist | 0.063 0.046 CID_45039956 0.071 0.032 CID_416254 | CID_416254 | |
| 0.074 | 0.077 | 0.09 | Caspase 7 inhibitor | 0.09 0.042 CID_19080 | CID_19080 | |
| 0.096 | 0.099 | 0.099 | Cell adhesion inhibitor | 0.099 0.09 CID_45039956 | CID_45039956 | |
| 0.056 | 0.061 | 0.067 | Bcl2 antagonist | 0.067 0.046 CID_416254 | CID_416254 | |
| 0.075 | 0.087 | 0.118 | Platelet activating factor alpha antagonist | 0.118 0.046 CID_19080 | CID_19080 | |
| 0.072 | 0.084 | 0.081 | Histamine H2 receptor antagonist | 0.081 0.063 CID_45039956 | CID_45039956 | |
| 0.043 | 0.055 | 0.052 | Sodium/calcium exchanger inhibitor | 0.052 0.031 CID_19080 | CID_19080 | |
| 0.027 | 0.039 | 0.042 | Estrogen-related receptor beta antagonist | 0.042 0.009 CID_19080 0.042 0.01 CID_416254 | CID_416254 | |
| 0.179 | 0.191 | 0.288 | Transcription factor NF kappa B inhibitor | 0.288 0.101 CID_19080 0.24 0.134 CID_416254 | CID_19080 | |
| 0.151 | 0.165 | 0.223 | Antioxidant | 0.223 0.099 CID_416254 | CID_416254 | |
| 0.064 | 0.079 | 0.15 | Platelet growth factor antagonist | 0.15 0.019 CID_19080 | CID_19080 | |
| 0.113 | 0.128 | 0.189 | Heat shock protein 90 antagonist | 0.141 0.084 CID_45039956 0.189 0.044 CID_19080 0.16 0.064 CID_416254 | CID_19080 | |
| 0.124 | 0.139 | 0.177 | Interleukin 6 antagonist | 0.177 0.057 CID_19080 0.138 0.109 CID_416254 | CID_19080 | |
| 0.036 | 0.054 | 0.045 | Neuraminidase (Influenza A) inhibitor | 0.045 0.032 CID_416254 | CID_416254 | |
| 0.041 | 0.06 | 0.05 | Potassium channel (Inward rectifier) activator | 0.05 0.035 CID_45039956 | CID_45039956 | |
| 0.039 | 0.059 | 0.048 | Potassium channel (ATP-sensitive) activator | 0.048 0.035 CID_45039956 | CID_45039956 | |
| 0.02 | 0.041 | 0.032 | Complement factor 1r inhibitor | 0.032 0.009 CID_19080 | CID_19080 | |
| 0.049 | 0.072 | 0.069 | Fibroblast growth factor 2 antagonist | 0.069 0.042 CID_19080 | CID_19080 | |
| 0.012 | 0.037 | 0.02 | Dopamine autoreceptor agonist | 0.02 0.019 CID_19080 | CID_19080 | |
| 0.043 | 0.071 | 0.069 | 5 Hydroxytryptamine 2A agonist | 0.069 0.038 CID_19080 | CID_19080 | |
| 0.044 | 0.073 | 0.054 | Adrenaline uptake inhibitor | 0.054 0.052 CID_19080 | CID_19080 | |
| 0.037 | 0.066 | 0.077 | Alpha 1d adrenoreceptor antagonist | 0.077 0.031 CID_19080 | CID_19080 | |
| 0.039 | 0.069 | 0.057 | Fibroblast growth factor 4 antagonist | 0.057 0.042 CID_19080 | CID_19080 | |
| 0.084 | 0.115 | 0.165 | Beta amyloid protein antagonist | 0.165 0.031 CID_19080 | CID_19080 | |
| 0.128 | 0.162 | 0.138 | Cyclin-dependent kinase 3 inhibitor | 0.138 0.127 CID_19080 | CID_19080 | |
| 0.037 | 0.071 | 0.079 | Topoisomerase II beta inhibitor | 0.079 0.013 CID_19080 0.057 0.024 CID_416254 | CID_19080 | |
| 0.119 | 0.154 | 0.176 | Interleukin antagonist | 0.176 0.099 CID_416254 | CID_416254 | |
| 0.044 | 0.079 | 0.089 | Alpha 1b adrenoreceptor antagonist | 0.089 0.04 CID_19080 | CID_19080 | |
| 0.028 | 0.064 | 0.097 | NMDA receptor subunit 3B antagonist | 0.09 0.012 CID_19080 0.097 0.011 CID_416254 | CID_416254 | |
| 0.075 | 0.113 | 0.166 | EphA2 antagonist | 0.166 0.023 CID_19080 | CID_19080 | |
| 0.128 | 0.167 | 0.179 | Focal adhesion kinase 2 inhibitor | 0.179 0.089 CID_19080 | CID_19080 | |
| 0.059 | 0.102 | 0.081 | Glycine receptor antagonist | 0.081 0.055 CID_416254 | CID_416254 | |
| 0.092 | 0.136 | 0.125 | Sphingosine 1-phosphate receptor 2 agonist | 0.125 0.048 CID_19080 | CID_19080 | |
| 0.108 | 0.154 | 0.196 | Heat shock protein 90 alpha antagonist | 0.148 0.089 CID_45039956 0.196 0.052 CID_19080 0.158 0.079 CID_416254 | CID_19080 | |
| 0.058 | 0.11 | 0.218 | Fibroblast growth factor 1 antagonist | 0.218 0.013 CID_19080 | CID_19080 | |
| 0.04 | 0.093 | 0.059 | 5 Hydroxytryptamine 7 agonist | 0.059 0.032 CID_19080 | CID_19080 | |
| 0.112 | 0.164 | 0.272 | Tumour necrosis factor antagonist | 0.272 0.024 CID_19080 | CID_19080 | |
| 0.07 | 0.124 | 0.093 | Nitric-oxide synthase inhibitor | 0.093 0.072 CID_45039956 | CID_45039956 | |
| 0.139 | 0.195 | 0.208 | Calpain inhibitor | 0.208 0.106 CID_45039956 | CID_45039956 | |
| 0.081 | 0.138 | 0.099 | CDK3/cyclin E inhibitor | 0.099 0.089 CID_45039956 | CID_45039956 | |
| 0.018 | 0.078 | 0.072 | NMDA receptor subunit 3A antagonist | 0.061 0.016 CID_19080 0.072 0.014 CID_416254 | CID_416254 | |
| 0.031 | 0.092 | 0.041 | Alpha 1L adrenoreceptor agonist | 0.041 0.036 CID_19080 | CID_19080 | |
| 0.033 | 0.094 | 0.055 | Myc inhibitor | 0.055 0.037 CID_45039956 | CID_45039956 | |
| 0.084 | 0.146 | 0.124 | Interleukin 8 antagonist | 0.124 0.056 CID_19080 0.122 0.059 CID_416254 | CID_19080 | |
| 0.121 | 0.186 | 0.219 | Immunostimulant | 0.219 0.109 CID_416254 | CID_416254 | |
| 0.051 | 0.117 | 0.126 | Calcium channel P-type blocker | 0.126 0.004 CID_19080 | CID_19080 | |
| 0.066 | 0.134 | 0.132 | Protein kinase C zeta inhibitor | 0.132 0.026 CID_19080 0.088 0.07 CID_416254 | CID_19080 | |
| 0.045 | 0.114 | 0.068 | Potassium channel large-conductance Ca-activated activator | 0.068 0.046 CID_19080 | CID_19080 | |
| 0.042 | 0.113 | 0.064 | Sirtuin 1 inhibitor | 0.064 0.053 CID_45039956 | CID_45039956 | |
| 0.049 | 0.121 | 0.064 | Beta 2 adrenoreceptor agonist | 0.064 0.034 CID_416254 | CID_416254 | |
| 0.061 | 0.135 | 0.198 | Platelet activating factor antagonist | 0.198 0.027 CID_19080 | CID_19080 | |
| 0.025 | 0.101 | 0.042 | 5 Hydroxytryptamine 2B agonist | 0.042 0.021 CID_19080 | CID_19080 | |
| 0.113 | 0.189 | 0.214 | Platelet aggregation inhibitor | 0.214 0.072 CID_19080 | CID_19080 | |
| 0.047 | 0.127 | 0.104 | Alpha adrenoreceptor antagonist | 0.104 0.054 CID_19080 | CID_19080 | |
| 0.034 | 0.119 | 0.052 | Epithelial sodium channel blocker | 0.052 0.044 CID_19080 | CID_19080 | |
| 0.147 | 0.234 | 0.183 | 5 Hydroxytryptamine 3E antagonist | 0.177 0.113 CID_45039956 0.183 0.098 CID_19080 | CID_19080 | |
| 0.064 | 0.151 | 0.113 | Electrolyte absorption antagonist | 0.113 0.042 CID_19080 0.087 0.079 CID_416254 | CID_19080 | |
| 0.032 | 0.12 | 0.099 | Alpha 1 adrenoreceptor antagonist | 0.099 0.044 CID_19080 | CID_19080 | |
| 0.017 | 0.107 | 0.068 | NMDA 2A receptor antagonist | 0.057 0.031 CID_19080 0.068 0.025 CID_416254 | CID_416254 | |
| 0.151 | 0.241 | 0.223 | Calpain 2 inhibitor | 0.223 0.169 CID_45039956 | CID_45039956 | |
| 0.153 | 0.245 | 0.223 | Insulysin inhibitor | 0.223 0.126 CID_416254 | CID_416254 | |
| 0.054 | 0.146 | 0.098 | Prolactin inhibitor | 0.098 0.057 CID_416254 | CID_416254 | |
| 0.059 | 0.152 | 0.091 | Interleukin 5 antagonist | 0.091 0.053 CID_19080 | CID_19080 | |
| 0.062 | 0.155 | 0.188 | GABA C receptor rho-1 antagonist | 0.094 0.071 CID_45039956 0.188 0.01 CID_19080 | CID_19080 | |
| 0.044 | 0.139 | 0.161 | Potassium channel (Ca-activated) activator | 0.161 0.024 CID_19080 0.084 0.071 CID_416254 | CID_19080 | |
| 0.117 | 0.214 | 0.166 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.166 0.111 CID_19080 | CID_19080 | |
| 0.071 | 0.168 | 0.106 | Calcium channel N-type blocker | 0.106 0.085 CID_19080 | CID_19080 | |
| 0.025 | 0.123 | 0.056 | 5 Hydroxytryptamine 4 antagonist | 0.056 0.029 CID_19080 | CID_19080 | |
| 0.157 | 0.257 | 0.2 | Apoptosis antagonist | 0.2 0.18 CID_19080 | CID_19080 | |
| 0.022 | 0.123 | 0.065 | NMDA 2C receptor antagonist | 0.058 0.048 CID_19080 0.065 0.039 CID_416254 | CID_416254 | |
| 0.065 | 0.167 | 0.087 | T cell inhibitor | 0.087 0.044 CID_19080 | CID_19080 | |
| 0.138 | 0.241 | 0.322 | Hypoxia-inducible factor 1 alpha inhibitor | 0.322 0.056 CID_19080 | CID_19080 | |
| 0.055 | 0.158 | 0.114 | c-Src kinase inhibitor | 0.114 0.079 CID_19080 | CID_19080 | |
| 0.089 | 0.196 | 0.124 | Insulin secretagoues | 0.124 0.105 CID_45039956 | CID_45039956 | |
| 0.021 | 0.128 | 0.052 | Acid-sensing ion channel blocker | 0.052 0.015 CID_19080 | CID_19080 | |
| 0.084 | 0.195 | 0.124 | Protein kinase (CK1) gamma 3 inhibitor | 0.124 0.122 CID_19080 | CID_19080 | |
| 0.06 | 0.172 | 0.096 | Histone deacetylase class III inhibitor | 0.096 0.094 CID_45039956 | CID_45039956 | |
| 0.075 | 0.188 | 0.307 | Peroxidase inhibitor | 0.307 0.036 CID_19080 0.225 0.053 CID_416254 | CID_19080 | |
| 0.089 | 0.203 | 0.172 | Anesthetic general | 0.172 0.093 CID_19080 | CID_19080 | |
| 0.013 | 0.129 | 0.04 | Estrogen-related receptor alpha antagonist | 0.04 0.018 CID_19080 | CID_19080 | |
| 0.085 | 0.204 | 0.135 | DNA repair enzyme inhibitor | 0.135 0.048 CID_19080 | CID_19080 | |
| 0.031 | 0.15 | 0.074 | Fibroblast growth factor 3 antagonist | 0.074 0.059 CID_19080 | CID_19080 | |
| 0.035 | 0.155 | 0.23 | Platelet activating factor beta antagonist | 0.23 0.019 CID_19080 | CID_19080 | |
| 0.068 | 0.189 | 0.129 | Src kinase inhibitor | 0.129 0.1 CID_19080 | CID_19080 | |
| 0.067 | 0.189 | 0.122 | Photosensitizer | 0.122 0.055 CID_19080 | CID_19080 | |
| 0.041 | 0.165 | 0.08 | Adrenaline agonist | 0.08 0.058 CID_416254 | CID_416254 | |
| 0.014 | 0.14 | 0.116 | Beta tubulin antagonist | 0.116 0.018 CID_19080 | CID_19080 | |
| 0.028 | 0.157 | 0.13 | Benzodiazepine agonist | 0.13 0.012 CID_19080 | CID_19080 | |
| 0.035 | 0.167 | 0.098 | Aryl hydrocarbon receptor antagonist | 0.098 0.014 CID_19080 | CID_19080 | |
| 0.012 | 0.145 | 0.051 | Dihydropteroate synthase inhibitor | 0.051 0.016 CID_19080 | CID_19080 | |
| 0.092 | 0.225 | 0.176 | Interleukin agonist | 0.176 0.143 CID_19080 | CID_19080 | |
| 0.017 | 0.151 | 0.082 | Alpha tubulin antagonist | 0.082 0.019 CID_19080 | CID_19080 | |
| 0.095 | 0.229 | 0.132 | MAP kinase 3 inhibitor | 0.132 0.103 CID_19080 | CID_19080 | |
| 0.022 | 0.157 | 0.201 | GABA A receptor antagonist | 0.201 0.005 CID_19080 | CID_19080 | |
| 0.065 | 0.201 | 0.172 | CDC-like kinase 1 inhibitor | 0.172 0.054 CID_19080 | CID_19080 | |
| 0.057 | 0.194 | 0.133 | Epidermal growth factor receptor kinase inhibitor | 0.133 0.06 CID_19080 | CID_19080 | |
| 0.038 | 0.181 | 0.089 | Ca(v)2.2 blocker | 0.089 0.057 CID_19080 | CID_19080 | |
| 0.151 | 0.295 | 0.228 | Interleukin 2 agonist | 0.228 0.145 CID_416254 | CID_416254 | |
| 0.082 | 0.229 | 0.128 | Sphingosine 1-phosphate receptor 2 antagonist | 0.128 0.078 CID_45039956 | CID_45039956 | |
| 0.051 | 0.199 | 0.144 | Bromodomain-containing protein 2 inhibitor | 0.144 0.011 CID_19080 | CID_19080 | |
| 0.048 | 0.196 | 0.242 | Cystathionine beta-synthase inhibitor | 0.242 0.016 CID_19080 | CID_19080 | |
| 0.079 | 0.226 | 0.204 | Amyloid beta precursor protein antagonist | 0.204 0.055 CID_19080 | CID_19080 | |
| 0.04 | 0.19 | 0.117 | Urease inhibitor | 0.117 0.048 CID_19080 | CID_19080 | |
| 0.02 | 0.171 | 0.205 | GABA receptor antagonist | 0.205 0.005 CID_19080 | CID_19080 | |
| 0.016 | 0.169 | 0.09 | Alpha 1a adrenoreceptor antagonist | 0.09 0.04 CID_19080 | CID_19080 | |
| 0.086 | 0.24 | 0.286 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.286 0.068 CID_19080 | CID_19080 | |
| 0.061 | 0.215 | 0.209 | Activin receptor-like kinase 2 inhibitor | 0.209 0.033 CID_19080 | CID_19080 | |
| 0.051 | 0.206 | 0.16 | GABA C receptor antagonist | 0.16 0.025 CID_19080 0.099 0.079 CID_416254 | CID_19080 | |
| 0.068 | 0.224 | 0.196 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.196 0.079 CID_19080 | CID_19080 | |
| 0.006 | 0.162 | 0.034 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.034 0.005 CID_19080 | CID_19080 | |
| 0.069 | 0.233 | 0.183 | Diuretic | 0.183 0.052 CID_19080 | CID_19080 | |
| 0.029 | 0.201 | 0.055 | Phosphodiesterase 1B inhibitor | 0.055 0.05 CID_19080 | CID_19080 | |
| 0.129 | 0.302 | 0.383 | 15-Lipoxygenase inhibitor | 0.383 0.082 CID_19080 | CID_19080 | |
| 0.066 | 0.243 | 0.226 | Pyruvate kinase inhibitor | 0.226 0.069 CID_19080 | CID_19080 | |
| 0.04 | 0.217 | 0.106 | Ephrin antagonist | 0.106 0.058 CID_19080 | CID_19080 | |
| 0.014 | 0.193 | 0.093 | NMDA 2 receptor antagonist | 0.093 0.036 CID_19080 0.069 0.052 CID_416254 | CID_19080 | |
| 0.062 | 0.241 | 0.654 | Aryl hydrocarbon receptor agonist | 0.654 0.011 CID_19080 | CID_19080 | |
| 0.09 | 0.271 | 0.201 | Succinate dehydrogenase inhibitor | 0.201 0.048 CID_19080 | CID_19080 | |
| 0.033 | 0.215 | 0.115 | M18 aspartyl aminopeptidase inhibitor | 0.115 0.075 CID_19080 | CID_19080 | |
| 0.035 | 0.219 | 0.055 | Ryanodine receptor antagonist | 0.055 0.054 CID_19080 | CID_19080 | |
| 0.027 | 0.211 | 0.09 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.09 0.043 CID_19080 | CID_19080 | |
| 0.042 | 0.226 | 0.156 | Glutamate receptor antagonist | 0.156 0.047 CID_19080 | CID_19080 | |
| 0.021 | 0.207 | 0.049 | GABA B receptor antagonist | 0.049 0.021 CID_19080 | CID_19080 | |
| 0.046 | 0.233 | 0.188 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.188 0.056 CID_19080 | CID_19080 | |
| 0.032 | 0.22 | 0.138 | Macrophage migration inhibitory factor inhibitor | 0.138 0.019 CID_19080 | CID_19080 | |
| 0.004 | 0.194 | 0.019 | Complement factor D inhibitor | 0.019 0.01 CID_19080 | CID_19080 | |
| 0.056 | 0.248 | 0.167 | NADPH oxidase inhibitor | 0.167 0.045 CID_19080 | CID_19080 | |
| 0.044 | 0.236 | 0.132 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.132 0.072 CID_19080 | CID_19080 | |
| 0.056 | 0.25 | 0.12 | Interleukin 1 antagonist | 0.12 0.088 CID_19080 | CID_19080 | |
| 0.017 | 0.211 | 0.072 | EphB4 antagonist | 0.072 0.028 CID_19080 | CID_19080 | |
| 0.032 | 0.229 | 0.086 | Alcohol dehydrogenase inhibitor | 0.086 0.07 CID_416254 | CID_416254 | |
| 0.041 | 0.238 | 0.221 | Tubulin antagonist | 0.221 0.031 CID_19080 | CID_19080 | |
| 0.045 | 0.244 | 0.226 | Amylase inhibitor | 0.226 0.035 CID_19080 | CID_19080 | |
| 0.011 | 0.21 | 0.08 | Fructose-1,6-bisphosphatase inhibitor | 0.08 0.007 CID_19080 | CID_19080 | |
| 0.041 | 0.24 | 0.161 | 5 Hydroxytryptamine 3A agonist | 0.161 0.03 CID_19080 | CID_19080 | |
| 0.039 | 0.241 | 0.141 | Vascular endothelial growth factor 3 antagonist | 0.141 0.073 CID_19080 | CID_19080 | |
| 0.048 | 0.252 | 0.14 | Growth factor antagonist | 0.14 0.076 CID_19080 | CID_19080 | |
| 0.027 | 0.232 | 0.049 | Heme oxygenase inhibitor | 0.049 0.015 CID_19080 | CID_19080 | |
| 0.158 | 0.363 | 0.357 | MAP kinase 1 inhibitor | 0.357 0.131 CID_19080 | CID_19080 | |
| 0.042 | 0.249 | 0.092 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.092 0.062 CID_19080 | CID_19080 | |
| 0.02 | 0.227 | 0.06 | Sphingosine 1-phosphate receptor 4 agonist | 0.06 0.054 CID_19080 | CID_19080 | |
| 0.029 | 0.236 | 0.071 | GABA aminotransferase inhibitor | 0.071 0.06 CID_19080 | CID_19080 | |
| 0.085 | 0.299 | 0.129 | Death-associated protein kinase 1 inhibitor | 0.129 0.083 CID_19080 | CID_19080 | |
| 0.045 | 0.262 | 0.111 | Lanosterol 14 alpha demethylase inhibitor | 0.111 0.04 CID_19080 | CID_19080 | |
| 0.05 | 0.269 | 0.117 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.117 0.111 CID_19080 | CID_19080 | |
| 0.033 | 0.252 | 0.062 | Phosphodiesterase 1C inhibitor | 0.062 0.043 CID_19080 | CID_19080 | |
| 0.052 | 0.271 | 0.115 | Estrogen antagonist | 0.115 0.064 CID_416254 | CID_416254 | |
| 0.026 | 0.246 | 0.087 | Check point kinase 2 inhibitor | 0.087 0.077 CID_19080 | CID_19080 | |
| 0.047 | 0.27 | 0.181 | CDC-like kinase 4 inhibitor | 0.181 0.078 CID_19080 | CID_19080 | |
| 0.049 | 0.272 | 0.148 | Carbonic anhydrase XV inhibitor | 0.148 0.031 CID_19080 | CID_19080 | |
| 0.081 | 0.308 | 0.296 | Neurotrophic factor enhancer | 0.296 0.019 CID_19080 | CID_19080 | |
| 0.101 | 0.332 | 0.233 | Cholesterol antagonist | 0.233 0.137 CID_19080 | CID_19080 | |
| 0.048 | 0.28 | 0.117 | D-Ala-D-Ala ligase inhibitor | 0.117 0.015 CID_19080 | CID_19080 | |
| 0.104 | 0.337 | 0.133 | Heat shock protein 70 antagonist | 0.133 0.105 CID_19080 | CID_19080 | |
| 0.07 | 0.307 | 0.122 | Adenylate cyclase stimulant | 0.122 0.121 CID_19080 | CID_19080 | |
| 0.004 | 0.242 | 0.027 | NMDA receptor glycine site antagonist | 0.027 0.015 CID_19080 | CID_19080 | |
| 0.043 | 0.282 | 0.2 | Clk dual-specificity kinase inhibitor | 0.2 0.079 CID_19080 | CID_19080 | |
| 0.008 | 0.249 | 0.035 | Inosine monophosphate dehydrogenase inhibitor | 0.035 0.026 CID_19080 | CID_19080 | |
| 0.039 | 0.28 | 0.102 | Estrogen receptor beta antagonist | 0.102 0.06 CID_416254 | CID_416254 | |
| 0.042 | 0.283 | 0.113 | Phosphodiesterase 7B inhibitor | 0.113 0.043 CID_19080 | CID_19080 | |
| 0.006 | 0.248 | 0.051 | Potassium channel small-conductance Ca-activated activator | 0.051 0.011 CID_19080 | CID_19080 | |
| 0.115 | 0.357 | 0.244 | Nitric-oxide synthase stimulant | 0.244 0.037 CID_19080 | CID_19080 | |
| 0.025 | 0.269 | 0.099 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.099 0.014 CID_19080 | CID_19080 | |
| 0.032 | 0.278 | 0.098 | Vascular endothelial growth factor antagonist | 0.098 0.083 CID_19080 | CID_19080 | |
| 0.024 | 0.271 | 0.088 | Vascular endothelial growth factor 2 antagonist | 0.088 0.081 CID_19080 | CID_19080 | |
| 0.051 | 0.303 | 0.242 | Dyrk kinase inhibitor | 0.242 0.076 CID_19080 | CID_19080 | |
| 0.05 | 0.304 | 0.228 | LIM domain kinase 1 inhibitor | 0.228 0.05 CID_19080 | CID_19080 | |
| 0.01 | 0.271 | 0.036 | Glutamate (mGluR3) antagonist | 0.036 0.026 CID_19080 | CID_19080 | |
| 0.07 | 0.333 | 0.126 | Pregnane X receptor agonist | 0.126 0.11 CID_19080 | CID_19080 | |
| 0.012 | 0.277 | 0.069 | NMDA receptor glycine site agonist | 0.069 0.038 CID_19080 | CID_19080 | |
| 0.035 | 0.304 | 0.141 | GABA receptor agonist | 0.141 0.041 CID_19080 | CID_19080 | |
| 0.039 | 0.309 | 0.107 | Carbonic anhydrase III inhibitor | 0.107 0.055 CID_19080 | CID_19080 | |
| 0.082 | 0.352 | 0.266 | 12-Lipoxygenase inhibitor | 0.266 0.1 CID_19080 | CID_19080 | |
| 0.056 | 0.327 | 0.113 | Sphingosine 1-phosphate receptor 4 antagonist | 0.113 0.087 CID_19080 | CID_19080 | |
| 0.043 | 0.313 | 0.077 | Thioredoxin reductase inhibitor | 0.077 0.071 CID_19080 | CID_19080 | |
| 0.047 | 0.318 | 0.117 | Toll-Like receptor 3 antagonist | 0.117 0.032 CID_19080 | CID_19080 | |
| 0.04 | 0.312 | 0.069 | MDM2 inhibitor | 0.069 0.041 CID_19080 | CID_19080 | |
| 0.023 | 0.296 | 0.055 | Pregnane X receptor antagonist | 0.055 0.045 CID_19080 | CID_19080 | |
| 0.054 | 0.328 | 0.26 | MAP kinase kinase 2 inhibitor | 0.26 0.05 CID_19080 | CID_19080 | |
| 0.035 | 0.31 | 0.088 | GABA B receptor agonist | 0.088 0.028 CID_19080 | CID_19080 | |
| 0.034 | 0.316 | 0.106 | Beta glucuronidase inhibitor | 0.106 0.061 CID_19080 | CID_19080 | |
| 0.014 | 0.301 | 0.044 | Adenylate cyclase 1 inhibitor | 0.044 0.035 CID_19080 | CID_19080 | |
| 0.031 | 0.318 | 0.053 | Immunoglobulin Fc receptor antagonist | 0.053 0.048 CID_19080 | CID_19080 | |
| 0.016 | 0.304 | 0.046 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.046 0.02 CID_19080 | CID_19080 | |
| 0.017 | 0.305 | 0.066 | Cyclin D1 inhibitor | 0.066 0.034 CID_19080 | CID_19080 | |
| 0.033 | 0.322 | 0.111 | Sodium channel (voltage-gated) blocker | 0.111 0.096 CID_19080 | CID_19080 | |
| 0.062 | 0.353 | 0.177 | Non-steroidal antiinflammatory agent | 0.177 0.09 CID_19080 | CID_19080 | |
| 0.005 | 0.296 | 0.017 | CC chemokine 9 receptor antagonist | 0.017 0.013 CID_19080 | CID_19080 | |
| 0.027 | 0.321 | 0.069 | Adenosine A3 receptor antagonist | 0.069 0.06 CID_19080 | CID_19080 | |
| 0.081 | 0.378 | 0.22 | Angiogenesis inhibitor | 0.22 0.148 CID_19080 | CID_19080 | |
| 0.022 | 0.322 | 0.084 | Pim-3 kinase inhibitor | 0.084 0.069 CID_19080 | CID_19080 | |
| 0.024 | 0.331 | 0.138 | Vascular endothelial growth factor 1 antagonist | 0.138 0.046 CID_19080 | CID_19080 | |
| 0.004 | 0.312 | 0.04 | Kynurenine 3 monooxygenase inhibitor | 0.04 0.01 CID_19080 | CID_19080 | |
| 0.025 | 0.335 | 0.114 | Glycogen synthase kinase-3 alpha inhibitor | 0.114 0.089 CID_19080 | CID_19080 | |
| 0.036 | 0.348 | 0.225 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.225 0.079 CID_19080 | CID_19080 | |
| 0.012 | 0.326 | 0.037 | Tryptophan 5 hydroxylase inhibitor | 0.037 0.022 CID_19080 | CID_19080 | |
| 0.059 | 0.379 | 0.223 | 3C-like protease (Human coronavirus) inhibitor | 0.223 0.04 CID_19080 | CID_19080 | |
| 0.087 | 0.414 | 0.203 | RNA-directed DNA polymerase inhibitor | 0.203 0.095 CID_19080 | CID_19080 | |
| 0.028 | 0.357 | 0.149 | CDC-like kinase 2 inhibitor | 0.149 0.094 CID_19080 | CID_19080 | |
| 0.029 | 0.36 | 0.116 | Alkaline phosphatase inhibitor | 0.116 0.091 CID_19080 | CID_19080 | |
| 0.032 | 0.374 | 0.086 | Transcription factor RelA inhibitor | 0.086 0.013 CID_19080 | CID_19080 | |
| 0.018 | 0.362 | 0.1 | Granulocyte macrophage colony stimulating factor antagonist | 0.1 0.072 CID_19080 | CID_19080 | |
| 0.028 | 0.377 | 0.115 | MAP kinase kinase 1 inhibitor | 0.115 0.039 CID_19080 | CID_19080 | |
| 0.059 | 0.409 | 0.201 | Lipoxygenase inhibitor | 0.201 0.139 CID_19080 | CID_19080 | |
| 0.017 | 0.379 | 0.059 | 5 Hydroxytryptamine 3 agonist | 0.059 0.051 CID_19080 | CID_19080 | |
| 0.023 | 0.385 | 0.084 | Creatine kinase inhibitor | 0.084 0.08 CID_416254 | CID_416254 | |
| 0.017 | 0.401 | 0.076 | Carbonic anhydrase XIII inhibitor | 0.076 0.053 CID_19080 | CID_19080 | |
| 0.034 | 0.433 | 0.166 | Arachidonic acid antagonist | 0.166 0.07 CID_19080 | CID_19080 | |
| 0.023 | 0.428 | 0.073 | Carbonic anhydrase VI inhibitor | 0.073 0.067 CID_19080 | CID_19080 | |
| 0.028 | 0.435 | 0.217 | I kappa B kinase epsilon inhibitor | 0.217 0.057 CID_19080 | CID_19080 | |
| 0.008 | 0.423 | 0.1 | Phosphodiesterase IV inhibitor | 0.1 0.045 CID_19080 | CID_19080 | |
| 0.008 | 0.426 | 0.069 | Phosphodiesterase 4B inhibitor | 0.069 0.045 CID_19080 | CID_19080 | |
| 0.029 | 0.459 | 0.189 | Mannose-6-phosphate isomerase inhibitor | 0.189 0.037 CID_19080 | CID_19080 | |
| 0.082 | 0.512 | 0.131 | Ca2+-transporting ATPase inhibitor | 0.131 0.116 CID_19080 | CID_19080 | |
| 0.03 | 0.461 | 0.113 | DOPA decarboxylase inhibitor | 0.113 0.054 CID_19080 | CID_19080 | |
| 0.014 | 0.468 | 0.115 | MAP kinase kinase inhibitor | 0.115 0.079 CID_19080 | CID_19080 | |
| 0.046 | 0.502 | 0.16 | CF transmembrane conductance regulator agonist | 0.16 0.06 CID_19080 | CID_19080 | |
| 0.045 | 0.503 | 0.13 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.13 0.116 CID_19080 | CID_19080 | |
| 0.033 | 0.503 | 0.25 | Alpha-glucosidase inhibitor | 0.25 0.187 CID_19080 | CID_19080 | |
| 0.014 | 0.484 | 0.064 | Glutamate (mGluR7) antagonist | 0.064 0.055 CID_19080 | CID_19080 | |
| 0.02 | 0.493 | 0.074 | Exportin-1 inhibitor | 0.074 0.034 CID_19080 | CID_19080 | |
| 0.022 | 0.504 | 0.135 | HIV-1 integrase (Overall Integration) inhibitor | 0.135 0.031 CID_19080 | CID_19080 | |
| 0.101 | 0.612 | 0.524 | Calcium channel L-type activator | 0.524 0.02 CID_19080 | CID_19080 | |
| 0.082 | 0.619 | 0.242 | MAP kinase kinase 6 inhibitor | 0.242 0.201 CID_19080 | CID_19080 | |
| 0.018 | 0.566 | 0.223 | Prostaglandin dehydrogenase inhibitor | 0.223 0.143 CID_19080 | CID_19080 | |
| 0.081 | 0.707 | 0.214 | MAP kinase kinase 3 inhibitor | 0.214 0.086 CID_19080 | CID_19080 | |
| 0.028 | 0.657 | 0.157 | Hexokinase inhibitor | 0.157 0.071 CID_19080 | CID_19080 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |